|
US5242904A
(en)
*
|
1987-06-05 |
1993-09-07 |
The Dupont Merck Pharmaceutical Company |
Peptide boronic acid inhibitors of trypsin-like proteases
|
|
DE3827340A1
(de)
*
|
1988-08-12 |
1990-02-15 |
Hoechst Ag |
Verwendung von (alpha)-aminoboronsaeure-derivaten zur prophylaxe und behandlung von viruserkrankungen
|
|
GB9017694D0
(en)
*
|
1990-08-13 |
1990-09-26 |
Sandoz Ltd |
Improvements in or relating to organic chemistry
|
|
WO1993021213A1
(en)
*
|
1992-04-16 |
1993-10-28 |
Zeneca Limited |
Alpha-aminoboronic acid peptides and their use as elastase inhibitors
|
|
CA2133657A1
(en)
*
|
1992-04-16 |
1993-10-28 |
Peter R. Bernstein |
Substituted derivatives
|
|
US5442100A
(en)
*
|
1992-08-14 |
1995-08-15 |
The Procter & Gamble Company |
β-aminoalkyl and β-N-peptidylaminoalkyl boronic acids
|
|
FR2701951B1
(fr)
*
|
1993-02-24 |
1995-06-09 |
Adir |
Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
IL111175A0
(en)
*
|
1993-10-07 |
1994-12-29 |
Du Pont Merck Pharma |
Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
|
|
US6060462A
(en)
*
|
1993-10-20 |
2000-05-09 |
Dupont Pharmaceuticals Company |
Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
|
|
US5693617A
(en)
*
|
1994-03-15 |
1997-12-02 |
Proscript, Inc. |
Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
|
|
FR2718451B1
(fr)
*
|
1994-04-12 |
1996-05-10 |
Synthelabo |
Dérivés de peptides boroniques, leur préparation et leur application en thérapeutique.
|
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
|
US5639739A
(en)
*
|
1995-03-24 |
1997-06-17 |
The Dupont Merck Pharmaceutical Company |
Imidazole containing aminoboronic acids
|
|
FR2739858B1
(fr)
*
|
1995-10-11 |
1997-11-14 |
Synthelabo |
Derives de n-sulfonyl- et n-sulfamoylpeptidylprolinamide, leur preparation et leur application en therapeutique
|
|
WO2002054931A2
(en)
*
|
2001-01-10 |
2002-07-18 |
Bristol Myers Squibb Company P |
Alpha-aminoboronic acids prepared by novel synthetic methods
|
|
CA2435124A1
(en)
*
|
2001-01-25 |
2002-08-01 |
Millennium Pharmaceuticals, Inc. |
Formulation of boronic acid compounds
|
|
EP1399468B1
(en)
*
|
2001-05-30 |
2006-02-15 |
Novartis AG |
2-((n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl)-amino)-alkylboronic acid derivatives
|
|
ES2264515T3
(es)
|
2002-09-09 |
2007-01-01 |
Trigen Limited |
Sales del acido boronico utiles en formulaciones parenterales para la inhibicion selectiva de la trombina.
|
|
US20050176651A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Trigen Limited |
Peptide boronic acids useful in making salts thereof
|
|
US20060084592A1
(en)
*
|
2002-09-09 |
2006-04-20 |
Trigen Limited |
Peptide boronic acid inhibitors
|
|
US20050282757A1
(en)
*
|
2002-09-09 |
2005-12-22 |
Trigen Limited |
Peptide boronic acid compounds useful in anticoagulation
|
|
US7371729B2
(en)
*
|
2002-09-09 |
2008-05-13 |
Trigen Limited |
Boronic acid salts useful in parenteral formulations
|
|
US20050119226A1
(en)
*
|
2003-09-09 |
2005-06-02 |
Trigen Limited |
Methods for synthesizing organoboronic compounds and products thereof
|
|
US7576206B2
(en)
|
2003-08-14 |
2009-08-18 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
US7223745B2
(en)
|
2003-08-14 |
2007-05-29 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
GB0405272D0
(en)
*
|
2004-03-09 |
2004-04-21 |
Trigen Ltd |
Compounds
|
|
PT2377869E
(pt)
*
|
2004-03-30 |
2014-04-15 |
Millennium Pharm Inc |
Síntese de bortezomib
|
|
US7468383B2
(en)
|
2005-02-11 |
2008-12-23 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
US20070059382A1
(en)
*
|
2005-09-09 |
2007-03-15 |
Board Of Regents, Univ. And Comm. College System Of Nevada... |
Medical treatment of breast cancer with boric acid materials
|
|
GEP20125599B
(en)
|
2007-08-06 |
2012-08-10 |
Millennium Pharm Inc |
Proteasome inhibitors
|
|
US7838673B2
(en)
*
|
2007-10-16 |
2010-11-23 |
Millennium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
US9212155B2
(en)
|
2008-03-19 |
2015-12-15 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
|
US10793515B2
(en)
|
2008-03-19 |
2020-10-06 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
|
AU2009225647C1
(en)
|
2008-03-19 |
2015-11-19 |
Aurimmed Pharma, Inc. |
Novel compounds advantageous in the treatment of central nervous system diseases and disorders
|
|
EA027346B1
(ru)
|
2008-06-17 |
2017-07-31 |
Милленниум Фармасьютикалз, Инк. |
Соединения боронатного эфира и его фармацевтические составы
|
|
AR075090A1
(es)
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
|
EP2344165A4
(en)
*
|
2008-10-01 |
2012-12-05 |
Reddys Lab Ltd Dr |
PHARMACEUTICAL COMPOSITIONS COMPRISING BORONIC ACID COMPOUNDS
|
|
EP2280016A1
(en)
|
2009-07-27 |
2011-02-02 |
LEK Pharmaceuticals d.d. |
New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
|
|
WO2010146172A2
(en)
|
2009-06-19 |
2010-12-23 |
Lek Pharmaceuticals D.D. |
NEW SYNTHETIC ROUTE FOR THE PREPARATION OF α-AMINO BORONIC ACID DERIVATIVES VIA SUBSTITUTED ALK-1-YNES
|
|
EP2270019A1
(en)
|
2009-06-19 |
2011-01-05 |
LEK Pharmaceuticals d.d. |
New synthetic route for the preparation of alpha-amino boronic esters
|
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
JP5783659B2
(ja)
|
2009-12-22 |
2015-09-24 |
セファロン、インク． |
プロテアソーム阻害剤およびその調製、精製および使用のための方法
|
|
MA34169B1
(fr)
|
2010-03-31 |
2013-04-03 |
Millennium Pharm Inc |
Dérivés d'acide 1-amino-2-cyclopropyléthylboronique
|
|
WO2012047845A1
(en)
|
2010-10-05 |
2012-04-12 |
App Pharmaceuticals |
Bortezomib formulations stabilised with boric
|
|
US10293048B2
(en)
|
2012-03-02 |
2019-05-21 |
Dr. Reddy's Laboratories Limited |
Pharmaceutical compositions comprising boronic acid compounds
|
|
WO2014072985A1
(en)
|
2012-11-06 |
2014-05-15 |
Natco Pharma Limited |
Novel boronic acid derivatives as anti cancer agents
|
|
EP2986619A1
(en)
|
2013-04-16 |
2016-02-24 |
Cipla Limited |
Process for the preparation of bortezomib mannitol ester
|
|
WO2015003146A1
(en)
|
2013-07-03 |
2015-01-08 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
|
US10167311B2
(en)
|
2014-02-03 |
2019-01-01 |
Ohio State Innovation Foundation |
Boronic acid esters and pharmaceutical formulations thereof
|
|
KR102509950B1
(ko)
|
2014-05-20 |
2023-03-14 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
일차 암 치료법 후 사용하기 위한 붕소-함유 프로테아좀 저해제
|
|
MA41505A
(fr)
|
2015-02-11 |
2017-12-19 |
Millennium Pharm Inc |
Nouvelle forme cristalline d'un inhibiteur de protéasome
|
|
EP3270891A1
(en)
|
2015-03-17 |
2018-01-24 |
Leon-Nanodrugs GmbH |
Nanoparticles comprising a stabilized boronic acid compound
|
|
WO2016205790A2
(en)
|
2015-06-19 |
2016-12-22 |
Hanlin Scientific, Inc. |
Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
|
|
US10526315B2
(en)
|
2016-06-21 |
2020-01-07 |
Orion Ophthalmology LLC |
Carbocyclic prolinamide derivatives
|
|
WO2017222915A1
(en)
|
2016-06-21 |
2017-12-28 |
Inception 4, Inc. |
Heterocyclic prolinamide derivatives
|